Author

Bin Zhang

Institution: Wuzhou Red Cross Hospital

Observed institutions: Central South University, Hunan Cancer Hospital, Wuzhou Red Cross Hospital

ORCID: 0000-0003-3765-4764

Observed ORCID: 0000-0003-3765-4764

OpenAlex ID: A5065512778

Identification of a novel mechanism for reversal of doxorubicin-induced chemotherapy resistance by TXNIP in triple-negative breast cancer via promoting reactive oxygen-mediated DNA damage

2022 · Yiting Chen, Xueping Feng, et al. · Cell Death and Disease · 68

Deubiquitylase USP12 induces pro-survival autophagy and bortezomib resistance in multiple myeloma by stabilizing HMGB1

2022 · Hui Li, Mridul Roy, et al. · Oncogene · 42

Research progress in MCM family: Focus on the tumor treatment resistance

2024 · Yuxuan Tian, Yanhong Zhou, et al. · Biomedicine & Pharmacotherapy · 23

XRCC2 driven homologous recombination subtypes and therapeutic targeting in lung adenocarcinoma metastasis

2024 · Han Gong, Peihe Zhang, et al. · npj Precision Oncology · 7

Integrated multiomic data analysis reveals the clinical significance of TXNIP and contributing to immune microenvironment in triple negative breast cancer

2023 · Han Gong, PeiHe Zhang, et al. · Translational Oncology · 6

Adjuvant apatinib therapy following concurrent chemoradiotherapy in patients with high-risk nasopharyngeal carcinoma: A multicenter, prospective phase 2 study

2026 · Chen Huang, Jinmei Huang, et al. · Translational Oncology

Works count: 6

Citation count: 146

H-index: 5

I10-index: 3